We are live on ! Find out more
Zurich Cantonal Bank

Zurich Cantonal Bank Portfolio holdings

AUM $46B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$22.7B
AUM Growth
+$2.11B
Cap. Flow
+$540M
Cap. Flow %
2.38%
Top 10 Hldgs %
29.27%
Holding
2,904
New
55
Increased
1,438
Reduced
459
Closed
109

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$61M
2
AAPL icon
Apple
AAPL
+$60.4M
3
GILD icon
Gilead Sciences
GILD
+$45.9M
4
ALC icon
Alcon
ALC
+$43.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$36.6M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$72.5M
2
PFE icon
Pfizer
PFE
+$45.3M
3
EBAY icon
eBay
EBAY
+$37.4M
4
MOS icon
The Mosaic Company
MOS
+$30.5M
5
KEYS icon
Keysight
KEYS
+$30.5M

Sector Composition

Rank Sector Weight
1 Technology 27.22%
2 Healthcare 15.42%
3 Financials 14.28%
4 Consumer Discretionary 9.68%
5 Industrials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMK
2051
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$150K ﹤0.01%
5,043
+1,185
+31% +$34.8K
CDMO
2052
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$149K ﹤0.01%
10,700
-2,645
-20% -$45.1K
CX icon
2053
Cemex
CX
$16.1B
$149K ﹤0.01%
20,998
-10,091
-32% -$64.2K
ACRS icon
2054
Aclaris Therapeutics
ACRS
$868M
$148K ﹤0.01%
14,243
+4,484
+46% +$40.6K
ADEA icon
2055
Adeia
ADEA
$3.04B
$148K ﹤0.01%
13,412
FRG
2056
DELISTED
Franchise Group, Inc.
FRG
$148K ﹤0.01%
5,153
RYTM icon
2057
Rhythm Pharmaceuticals
RYTM
$7.94B
$148K ﹤0.01%
8,949
-159
-2% -$2.87K
KE
2058
Kimball Electronics
KE
$607M
$148K ﹤0.01%
5,339
+3,363
+170% +$79.6K
AZZ icon
2059
AZZ Inc
AZZ
$4.64B
$147K ﹤0.01%
3,391
SII
2060
Sprott
SII
$3.04B
$147K ﹤0.01%
4,540
+1,037
+30% +$35.8K
PWSC
2061
DELISTED
PowerSchool Holdings, Inc.
PWSC
$147K ﹤0.01%
7,673
GSHD icon
2062
Goosehead Insurance
GSHD
$2.29B
$147K ﹤0.01%
2,335
MCRB icon
2063
Seres Therapeutics
MCRB
$47.8M
$147K ﹤0.01%
1,530
+329
+27% +$35.8K
ORGN
2064
DELISTED
Origin Materials
ORGN
$146K ﹤0.01%
1,141
+310
+37% +$39.9K
ACT icon
2065
Enact Holdings
ACT
$6.74B
$145K ﹤0.01%
5,774
GDEN
2066
DELISTED
Golden Entertainment
GDEN
$145K ﹤0.01%
3,463
AZN icon
2067
AstraZeneca
AZN
$249B
$144K ﹤0.01%
1,009
SPTN
2068
DELISTED
SpartanNash
SPTN
$144K ﹤0.01%
6,381
GOLD
2069
Gold.com Inc
GOLD
$1.25B
$143K ﹤0.01%
3,831
GDOT icon
2070
Green Dot
GDOT
$748M
$143K ﹤0.01%
7,652
CUBI icon
2071
Customers Bancorp
CUBI
$2.79B
$143K ﹤0.01%
4,737
+1,948
+70% +$43.7K
OLO
2072
DELISTED
Olo Inc
OLO
$143K ﹤0.01%
22,187
RGNX icon
2073
Regenxbio
RGNX
$694M
$143K ﹤0.01%
7,161
+1,952
+37% +$37.6K
FIZZ icon
2074
National Beverage
FIZZ
$2.87B
$143K ﹤0.01%
2,956
AVPT icon
2075
AvePoint
AVPT
$2.77B
$143K ﹤0.01%
24,777

Similar funds

Zurich Cantonal Bank's Q2 2023 Portfolio in Review

As of Q2 2023, Zurich Cantonal Bank held 2,904 positions worth $22.7B, up 10% from $20.5B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Zurich Cantonal Bank's Q2 2023 filing shows 55 new, 1,438 increased, 459 reduced and 109 closed positions. Its largest new stake was monday.com: 5,910 shares worth $1.01M. The largest sale was AbbVie, an estimated $72.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Zurich Cantonal Bank's largest Q2 2023 buy was monday.com: 5,910 shares worth $1.01M.
  • Zurich Cantonal Bank added most to Adobe in Q2 2023, an estimated $61M increase.
  • Zurich Cantonal Bank's biggest Q2 2023 reduction was AbbVie, cutting an estimated $72.5M.
  • Zurich Cantonal Bank fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $17.2M.
  • Zurich Cantonal Bank's ten largest holdings make up 29% of its $22.7B portfolio in Q2 2023.
  • Zurich Cantonal Bank opened 55 new positions and closed 109 in Q2 2023.
  • Zurich Cantonal Bank's portfolio value rose 10% quarter-over-quarter to $22.7B.

Based on Zurich Cantonal Bank's 13F filing for Q2 2023, filed 7 Aug 2023.